Record Q4 2020 revenue of $3.8 million up 149% over prior year
Full year 2020 revenue of $7.6 million up 98% vs. 2019
Q4 gross margin of 73% up 100 basis points over prior year
Q4 cash used in operations of $1.2 million lowest since June 2017 IPO
Conference call begins at 4:30 p.m. Eastern time today
BOSTON, Mass. (March 10, 2021) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced financial results for the three months and year ended December 31, 2020. Read more.